CTOs on the Move

Custom Spine Inc

www.customspine.com

 
Custom Spine Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Parsippany, NJ. To find more information about Custom Spine Inc, please visit www.customspine.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.customspine.com
  • 1140 Parsippany Blvd Ste 201
    Parsippany, NJ USA 07054-1887
  • Phone: 973.808.0019

Executives

Name Title Contact Details

Similar Companies

Georgia Pediatric Pulmonology Associates

Georgia Pediatric Pulmonology Associates is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.

Swisher Hygiene

Swisher Hygiene is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Charlotte, NC. To find more information about Swisher Hygiene, please visit www.swisherhygiene.com

Tulare Cnty Alcoholism Council

Tulare Cnty Alcoholism Council is a Visalia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthReveal

HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.